XinyuVon ButtlarMDMS
Internal Medicine • Memphis, TNHematology/Oncology
Hematology/Oncology Fellow, PGY-4
Dr. Von Buttlar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
920 Madison ave
Memphis, TN 38104
Education & Training
University of TennesseeFellowship, Hematology and Medical Oncology, 2022 - 2025
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2019 - 2022
University of Tennessee Health Science Center College of MedicineClass of 2019
Certifications & Licensure
DC State Medical License 2019 - 2022
VA State Medical License 2019 - 2022- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 21 citationsKDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma.Alexandra D'Oto, Jie Fang, Hongjian Jin, Beisi Xu, Shivendra Singh
Nature Communications. 2021-12-10 - 7 citationsBrentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patients.Jamie E. Flerlage, Xinyu von Buttlar, Matthew J. Krasin, Brandon M. Triplett, Sue C. Kaste
Pediatric Blood & Cancer. 2019-08-20 - 3 citationsEML4-ALK Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case Report.Xinyu von Buttlar, Joshua E. Reuss, Stephen V. Liu, Chul Kim
JTO Clinical and Research Reports. 2021-04-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
